Daito Pharmaceutical Co.,Ltd. Stock Price

TSE:4577 Community·JP¥43.6b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

4577 Share Price Performance

JP¥1,494.00

419.00 (38.98%)

JP¥1,494.00

419.00 (38.98%)

JP¥1,494.00

Sat, 7 Mar 26

Share Pricen/a

4577 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet established dividend payer.

0 Risks

3 Rewards

View Full Analysis

Daito Pharmaceutical Co.,Ltd. Key Details

Last Reported Earnings

Nov 30, 2025

Next Reporting Earnings

n/a

: 76.57
: 17.63%
: 4.36%
: 15.4%

View Full Analysis

About 4577

Founded: 1942
Employees: 1073
CEO: Hiroshi Matsumori
WebsiteView website: www.daitonet.co.jp

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.